{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33762356",
  "DateCompleted": {
    "Year": "2021",
    "Month": "11",
    "Day": "04"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "11",
    "Day": "04"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "03",
        "Day": "24"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1158/0008-5472.CAN-20-3730"
    ],
    "Journal": {
      "ISSN": "1538-7445",
      "JournalIssue": {
        "Volume": "81",
        "Issue": "11",
        "PubDate": {
          "Year": "2021",
          "Month": "Jun",
          "Day": "01"
        }
      },
      "Title": "Cancer research",
      "ISOAbbreviation": "Cancer Res"
    },
    "ArticleTitle": "Oncometabolites in Cancer: Current Understanding and Challenges.",
    "Pagination": {
      "StartPage": "2820",
      "EndPage": "2823",
      "MedlinePgn": "2820-2823"
    },
    "Abstract": {
      "AbstractText": [
        "Oncometabolites are pathognomonic hallmarks in human cancers, including glioma, leukemia, neuroendocrine tumors, and renal cancer. Oncometabolites are aberrantly accumulated from disrupted Krebs cycle and affect the catalytic activity of \u03b1-ketoglutarate-dependent dioxygenases. Oncometabolites indicate distinct cancer-related patterns ranging from oncogenesis and metabolism to therapeutic resistance. Here we discuss the current understanding of oncometabolites as well as the controversies and challenges associated with oncometabolite-driven cancers. New insights into the relationship between cancer and oncometabolites will elucidate novel therapeutic avenues for improved cancer treatment."
      ],
      "CopyrightInformation": "\u00a92021 American Association for Cancer Research."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Neuro-Oncology Branch, Center for Cancer Research, NCI, Bethesda, Maryland."
          }
        ],
        "LastName": "Liu",
        "ForeName": "Yang",
        "Initials": "Y"
      },
      {
        "Identifier": [
          "0000-0001-6433-0867"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Neuro-Oncology Branch, Center for Cancer Research, NCI, Bethesda, Maryland. yangc2@nih.gov."
          }
        ],
        "LastName": "Yang",
        "ForeName": "Chunzhang",
        "Initials": "C"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Intramural",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Cancer Res",
    "NlmUniqueID": "2984705R",
    "ISSNLinking": "0008-5472"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Carcinogenesis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Citric Acid Cycle"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Metabolome"
    },
    {
      "QualifierName": [
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Neoplasms"
    }
  ]
}